A UK COST-UTILITY ANALYSIS OF FERRIC CARBOXYMALTOSE VERSUS FERRIC DERISOMALTOSE IN PATIENTS WITH IRON DEFICIENCY ANEMIA AND INFLAMMATORY BOWEL DISEASE: INCORPORATION OF FRACTURE DATA

被引：0
|
作者：
Zoller, H. [1 ]
Pammer, L. M. [1 ]
Nottmeier, M. [2 ]
Poehlmann, J. [3 ]
Pollock, R. F. [3 ]
机构：
[1] Med Univ Innsbruck, Innsbruck, Austria
[2] Pharmacosmos AS, Ballerup 84, Denmark
[3] Covalence Res Ltd, Harpenden, Herts, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE68
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [31] Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial
    Zoller, Heinz
    Wolf, Myles
    Blumenstein, Irina
    Primas, Christian
    Lindgren, Stefan
    Thomsen, Lars L.
    Reinisch, Walter
    Iqbal, Tariq
    GUT, 2023, 72 (04) : 644 - 653
  • [32] Efficacy and safety of a restrictive ferric carboxymaltose infusion strategy for iron deficiency anemia in inflammatory bowel disease patients
    Crispino, F.
    Grova, M.
    Maida, M.
    Renna, S.
    Casa, A.
    Rizzo, G.
    Macaluso, F. S.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S292 - S292
  • [33] Ferric Carboxymaltose Prevents Recurrence of Anemia in Patients With Inflammatory Bowel Disease
    Evstatiev, Rayko
    Alexeeva, Olga
    Bokemeyer, Bernd
    Chopey, Ivan
    Felder, Marcel
    Gudehus, Maja
    Iqbal, Tariq
    Khalif, Igor
    Marteau, Philippe
    Stein, Juergen
    Gasche, Christoph
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (03) : 269 - 277
  • [34] Effects of ferric derisomaltose and ferric carboxymaltose on hypophosphatemia in iron-deficiency anaemia due to Inflammatory Bowel Disease: A Phase IV randomised clinical trial
    Zoller, H.
    Wolf, M.
    Blumenstein, I.
    Primas, C.
    Lindgren, S.
    Thomsen, L. L.
    Reinisch, W.
    Iqbal, I.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S121 - S121
  • [35] Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia
    Cococcioni, Lucia
    Pensabene, Licia
    El-Khouly, Sara
    Chadokufa, Sibongile
    McCartney, Sara
    Saliakellis, Efstratios
    Kiparissi, Fevronia
    Borrelli, Osvaldo
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (07) : 830 - 834
  • [36] Efficacy and Cost Effectiveness of Intravenous Ferric Carboxymaltose Versus Iron Sucrose in Adult Patients with Iron Deficiency Anemia
    Basha, Ahmed
    Izham, Mohamed
    Hamad, Anas
    Chandra, Prem
    Omar, Nabil E.
    Abdulla, Mohammad Abdul-Jaber
    Aldapt, Mahmood B.
    Hussein, Radwa M.
    Mahfouz, Ahmed
    Adel, Ahmed A.
    Shwaylia, Hawraa M.
    Ekeibed, Yeslem Mohamed Aly
    AbuMousa, Rami
    Yassin, Mohamed A.
    BLOOD, 2020, 136
  • [37] Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose
    Hu, Shanlian
    Liu, Limin
    Pollock, Richard F.
    Pohlmann, Johannes
    Wu, Depei
    Zhang, Yabing
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 561 - 570
  • [38] The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease
    Koduru, Pramoda
    Abraham, Bincy P.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (01) : 76 - 85
  • [39] IV IRON TREATMENT OF IRON DEFICIENCY ANEMIA WITH FERUMOXYTOL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNABLE TO TAKE ORAL IRON: A RANDOMIZED CONTROLLED TRIAL VERSUS FERRIC CARBOXYMALTOSE
    Strauss, William
    Dahl, Naomi V.
    Jiang, John
    GASTROENTEROLOGY, 2019, 156 (06) : S1107 - S1108
  • [40] Ferric derisomaltose versus usual care in patients with heart failure, reduced ejection fraction, and iron deficiency: a short-term UK cost-utility analysis based on the IRONMAN RCT
    Pollock, R.
    Kalra, P. R.
    Mcmurray, J. J., V
    Graham, F. J.
    Pellicori, P.
    Cleland, J. G. F.
    Ford, I
    EUROPEAN HEART JOURNAL, 2024, 45
12345